|
|
|
| Unlocking The Power Of Primary Care In Chronic Disease Research | Primary care physicians are a vital yet underused resource in chronic disease research. Engaging PCPs expands access to diverse patient populations, speeds patient identification, improves long term retention, and provides real world insights into treatment effectiveness. This session explores how to effectively involve PCPs, including their role in disease management, best practices for training and support, and navigating global regulations when integrating PCPs into clinical research. Click here to learn more. |
|
|
|
| Trials Without Borders: New UK Clinical Trial Regulations | Video | Clinical Leader | The UK is undergoing its most significant overhaul of clinical trials regulations in decades, and U.S. sponsors need to take notice. In this episode of Trials Without Borders, brought to you by Clinical Leader and FlexPoint Bio, host Elena Sinclair and co-host Ross Jackson sit down with UK-based experts to unpack what's changing and where American biotechs most often stumble. |
|
|
|
|
|
|
|
| Webinar: Execution Without Direction: The Hidden Risk in Outsourced Clinical Trials | As outsourcing expands, clinical trial success increasingly depends on stronger sponsor-CRO alignment. This webinar explores the growing disconnect between sponsors, CROs, CRAs, and sites, and how fragmented operations can impact execution. Hear practical strategies to improve oversight, strengthen collaboration, reduce risk, and build more cohesive, site-friendly, high-performing clinical trial operations from start to finish. Click here to learn more. |
|
|
|
|
|
| Controlled Substances In Clinical Trials | Article | By Rich Nelson, John Hufnagel, and Rachel Castro, PCI Pharma Services | Handling controlled substances presents layers of complexity. Partnering with an experienced CDMO is essential for managing scheduled materials during clinical studies. |
|
|
|
| Hematology Clinical Development | Datasheet | IQVIA Biotech | Hematology trials need strategies for complex endpoints, advanced therapies, and global compliance. Predictive analytics and tailored approaches accelerate timelines and optimize recruitment. |
|
|
|
|
| AI Meets Informed Consent: Opportunity, Risk, and What IRBs Need to See | As generative AI begins shaping how consent materials are created and delivered, sponsors and CROs face new ethical and regulatory challenges. This session explores core consent principles, emerging AI applications, and what IRBs need to know. Clinical operations leaders will gain a framework for evaluating AI assisted consent tools, improving IRB collaboration, and protecting participant understanding and autonomy. Click here to learn more. |
|
|
CHOOSE YOUR OWN ADVENTURE |
|
|
|
| You're receiving the Thursday edition of the Clinical Leader newsletter, focusing on Outsourcing Models and Regulatory & Compliance. To make changes to your newsletter selections, update your topic preferences. - Clinical Sites | Patient Centricity | Patient Recruitment (Monday)
- Clinical Trial Technology (Tuesday)
- Decentralized Trials | Trial Management (Wednesday)
- Outsourcing Models | Regulatory & Compliance (Thursday)
- Clinical Data Management & Analytics | Trial Monitoring (Friday)
Learn more about our personalized newsletters here. |
|
|
| Connect With Clinical Leader: |
|
|
|
